1Anno·

Valuation Healthcare sector - Goldman Sachs

9
5 Commenti

immagine del profilo
I still have one US pharma share on my buy list.
But I'm wondering whether I should get in before August.
•
2
•
immagine del profilo
@Tenbagger2024 I don't think anyone can answer that 😁. I think the healthcare sector for diversification is certainly not a mistake at the moment.
•
1
•
immagine del profilo
@BamBamInvest However, there will probably be significant gaps in developments between pharma, biotech, medtech and health insurers/healthcare.

For my taste, the assessments of the sector have been far too crude here recently and little substantiated information has been provided other than arguments of size and relevance for individual market players (cf. also LVMH hype a few months ago, where the key argument was always: hey, come on, it's LVMH, what could possibly go wrong🫣).
•
2
•
Visualizza un'altra risposta
Utente eliminato
1Anno
Il commento è stato cancellato
immagine del profilo
@Michey777 I see it the same way 👌
••
Partecipa alla conversazione